nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—ADRB1—dilated cardiomyopathy	0.515	0.543	CbGaD
Nebivolol—ADRB2—dilated cardiomyopathy	0.433	0.457	CbGaD
Nebivolol—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00228	0.0535	CcSEcCtD
Nebivolol—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00188	0.0442	CcSEcCtD
Nebivolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00168	0.0393	CcSEcCtD
Nebivolol—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00101	0.0237	CcSEcCtD
Nebivolol—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000931	0.0218	CcSEcCtD
Nebivolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.00092	0.0216	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000893	0.0209	CcSEcCtD
Nebivolol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000822	0.0193	CcSEcCtD
Nebivolol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000762	0.0179	CcSEcCtD
Nebivolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000732	0.0172	CcSEcCtD
Nebivolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000731	0.0171	CcSEcCtD
Nebivolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.000717	0.0792	CbGpPWpGaD
Nebivolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000708	0.0166	CcSEcCtD
Nebivolol—Malnutrition—Furosemide—dilated cardiomyopathy	0.00069	0.0162	CcSEcCtD
Nebivolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000684	0.016	CcSEcCtD
Nebivolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000684	0.016	CcSEcCtD
Nebivolol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000658	0.0154	CcSEcCtD
Nebivolol—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000653	0.0153	CcSEcCtD
Nebivolol—Rash—Spironolactone—dilated cardiomyopathy	0.000652	0.0153	CcSEcCtD
Nebivolol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000652	0.0153	CcSEcCtD
Nebivolol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000649	0.0152	CcSEcCtD
Nebivolol—Headache—Spironolactone—dilated cardiomyopathy	0.000648	0.0152	CcSEcCtD
Nebivolol—Vertigo—Furosemide—dilated cardiomyopathy	0.00062	0.0145	CcSEcCtD
Nebivolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000615	0.0144	CcSEcCtD
Nebivolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000605	0.0142	CcSEcCtD
Nebivolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.000594	0.0656	CbGpPWpGaD
Nebivolol—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000586	0.0137	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000583	0.0137	CcSEcCtD
Nebivolol—Shock—Furosemide—dilated cardiomyopathy	0.000554	0.013	CcSEcCtD
Nebivolol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000552	0.0129	CcSEcCtD
Nebivolol—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000551	0.0129	CcSEcCtD
Nebivolol—Skin disorder—Furosemide—dilated cardiomyopathy	0.000547	0.0128	CcSEcCtD
Nebivolol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000521	0.0122	CcSEcCtD
Nebivolol—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000518	0.0121	CcSEcCtD
Nebivolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000505	0.0118	CcSEcCtD
Nebivolol—Somnolence—Furosemide—dilated cardiomyopathy	0.0005	0.0117	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000486	0.0114	CcSEcCtD
Nebivolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000485	0.0114	CcSEcCtD
Nebivolol—Angioedema—Lisinopril—dilated cardiomyopathy	0.000473	0.0111	CcSEcCtD
Nebivolol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000465	0.0109	CcSEcCtD
Nebivolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000464	0.0109	CcSEcCtD
Nebivolol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00046	0.0108	CcSEcCtD
Nebivolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000455	0.0107	CcSEcCtD
Nebivolol—Urticaria—Furosemide—dilated cardiomyopathy	0.000447	0.0105	CcSEcCtD
Nebivolol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000445	0.0104	CcSEcCtD
Nebivolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000441	0.0103	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000438	0.0103	CcSEcCtD
Nebivolol—Shock—Lisinopril—dilated cardiomyopathy	0.000416	0.00974	CcSEcCtD
Nebivolol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000415	0.00972	CcSEcCtD
Nebivolol—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000414	0.00969	CcSEcCtD
Nebivolol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00041	0.00962	CcSEcCtD
Nebivolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000404	0.00947	CcSEcCtD
Nebivolol—Pruritus—Furosemide—dilated cardiomyopathy	0.000398	0.00934	CcSEcCtD
Nebivolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000385	0.00903	CcSEcCtD
Nebivolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.000382	0.00896	CcSEcCtD
Nebivolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000379	0.00889	CcSEcCtD
Nebivolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000377	0.00883	CcSEcCtD
Nebivolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000375	0.0088	CcSEcCtD
Nebivolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000372	0.00873	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000365	0.00855	CcSEcCtD
Nebivolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000364	0.00854	CcSEcCtD
Nebivolol—Vomiting—Furosemide—dilated cardiomyopathy	0.000358	0.00839	CcSEcCtD
Nebivolol—Rash—Furosemide—dilated cardiomyopathy	0.000355	0.00832	CcSEcCtD
Nebivolol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000355	0.00831	CcSEcCtD
Nebivolol—Headache—Furosemide—dilated cardiomyopathy	0.000353	0.00827	CcSEcCtD
Nebivolol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000345	0.0081	CcSEcCtD
Nebivolol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000336	0.00787	CcSEcCtD
Nebivolol—Nausea—Furosemide—dilated cardiomyopathy	0.000334	0.00784	CcSEcCtD
Nebivolol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000334	0.00783	CcSEcCtD
Nebivolol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000311	0.00729	CcSEcCtD
Nebivolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000303	0.0071	CcSEcCtD
Nebivolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000299	0.00701	CcSEcCtD
Nebivolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000289	0.00677	CcSEcCtD
Nebivolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000279	0.00655	CcSEcCtD
Nebivolol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000269	0.0063	CcSEcCtD
Nebivolol—Rash—Lisinopril—dilated cardiomyopathy	0.000266	0.00624	CcSEcCtD
Nebivolol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000266	0.00624	CcSEcCtD
Nebivolol—Headache—Lisinopril—dilated cardiomyopathy	0.000265	0.0062	CcSEcCtD
Nebivolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000254	0.028	CbGpPWpGaD
Nebivolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000251	0.00588	CcSEcCtD
Nebivolol—HTR1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000248	0.0274	CbGpPWpGaD
Nebivolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000213	0.0236	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000212	0.0235	CbGpPWpGaD
Nebivolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00021	0.0232	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000208	0.023	CbGpPWpGaD
Nebivolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000207	0.0228	CbGpPWpGaD
Nebivolol—HTR1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000201	0.0222	CbGpPWpGaD
Nebivolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000177	0.0195	CbGpPWpGaD
Nebivolol—HTR1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000169	0.0187	CbGpPWpGaD
Nebivolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000164	0.0181	CbGpPWpGaD
Nebivolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000163	0.018	CbGpPWpGaD
Nebivolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000161	0.0177	CbGpPWpGaD
Nebivolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00016	0.0176	CbGpPWpGaD
Nebivolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000156	0.0173	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000151	0.0167	CbGpPWpGaD
Nebivolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.00015	0.0165	CbGpPWpGaD
Nebivolol—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000141	0.0156	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000132	0.0146	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000129	0.0143	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000127	0.014	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000116	0.0129	CbGpPWpGaD
Nebivolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000108	0.0119	CbGpPWpGaD
Nebivolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	8.79e-05	0.00972	CbGpPWpGaD
Nebivolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	7.59e-05	0.00839	CbGpPWpGaD
Nebivolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	7.28e-05	0.00805	CbGpPWpGaD
Nebivolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	6.92e-05	0.00764	CbGpPWpGaD
Nebivolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	6.41e-05	0.00708	CbGpPWpGaD
Nebivolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	6.29e-05	0.00695	CbGpPWpGaD
Nebivolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	6.27e-05	0.00692	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	5.91e-05	0.00653	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	5.73e-05	0.00633	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	5.73e-05	0.00633	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.56e-05	0.00614	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.44e-05	0.00601	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	5.32e-05	0.00588	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.31e-05	0.00587	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	5.17e-05	0.00571	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	5.12e-05	0.00566	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	5.05e-05	0.00558	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	4.94e-05	0.00546	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	4.89e-05	0.00541	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	4.79e-05	0.00529	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.76e-05	0.00526	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.76e-05	0.00526	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.66e-05	0.00514	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.66e-05	0.00514	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.55e-05	0.00503	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.55e-05	0.00503	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.43e-05	0.00489	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.33e-05	0.00478	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.27e-05	0.00472	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.23e-05	0.00468	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	4.19e-05	0.00463	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.18e-05	0.00462	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	4.1e-05	0.00453	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.09e-05	0.00452	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	4.05e-05	0.00448	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	3.88e-05	0.00428	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.66e-05	0.00404	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.63e-05	0.00401	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.63e-05	0.00401	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.58e-05	0.00396	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.55e-05	0.00392	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.55e-05	0.00392	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.5e-05	0.00387	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	3.47e-05	0.00384	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.47e-05	0.00383	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.47e-05	0.00383	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.37e-05	0.00372	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	3.32e-05	0.00367	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.3e-05	0.00364	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.22e-05	0.00356	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	3.19e-05	0.00353	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	3.12e-05	0.00345	CbGpPWpGaD
Nebivolol—HTR1A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	3.1e-05	0.00342	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.79e-05	0.00308	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.73e-05	0.00301	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.67e-05	0.00295	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	2.64e-05	0.00292	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.58e-05	0.00285	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	2.53e-05	0.00279	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.52e-05	0.00278	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.46e-05	0.00272	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.05e-05	0.00226	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.05e-05	0.00226	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2e-05	0.00221	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2e-05	0.00221	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	1.96e-05	0.00217	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.96e-05	0.00216	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.96e-05	0.00216	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.95e-05	0.00215	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	1.92e-05	0.00212	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.9e-05	0.0021	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	1.88e-05	0.00207	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.86e-05	0.00206	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.86e-05	0.00206	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.86e-05	0.00206	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.82e-05	0.00201	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.82e-05	0.00201	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.82e-05	0.00201	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.8e-05	0.00199	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.78e-05	0.00197	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.78e-05	0.00197	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.76e-05	0.00195	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.73e-05	0.00191	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.72e-05	0.0019	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.69e-05	0.00187	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.65e-05	0.00183	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.64e-05	0.00181	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.62e-05	0.00179	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.6e-05	0.00177	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.58e-05	0.00174	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.54e-05	0.0017	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.51e-05	0.00166	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.49e-05	0.00165	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.46e-05	0.00162	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.43e-05	0.00158	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.43e-05	0.00158	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.4e-05	0.00155	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.37e-05	0.00151	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.36e-05	0.0015	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.3e-05	0.00143	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.24e-05	0.00137	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.21e-05	0.00134	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.18e-05	0.00131	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.16e-05	0.00128	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.13e-05	0.00125	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.11e-05	0.00123	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.11e-05	0.00122	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.1e-05	0.00121	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.1e-05	0.00121	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.08e-05	0.0012	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.08e-05	0.00119	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.08e-05	0.00119	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.06e-05	0.00117	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.05e-05	0.00116	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.05e-05	0.00116	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.05e-05	0.00116	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.03e-05	0.00114	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.02e-05	0.00113	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.01e-05	0.00111	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.01e-05	0.00111	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.99e-06	0.0011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	9.85e-06	0.00109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.77e-06	0.00108	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.68e-06	0.00107	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	9.63e-06	0.00106	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.46e-06	0.00105	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.45e-06	0.000934	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.27e-06	0.000913	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.08e-06	0.000893	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.02e-06	0.000886	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.67e-06	0.000847	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.99e-06	0.000772	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.89e-06	0.000761	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.83e-06	0.000755	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.74e-06	0.000745	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.68e-06	0.000738	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.59e-06	0.000728	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.22e-06	0.000688	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.09e-06	0.000673	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	5.95e-06	0.000658	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	5.95e-06	0.000657	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	5.82e-06	0.000643	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	5.69e-06	0.000628	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.79e-06	0.000529	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.69e-06	0.000518	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.58e-06	0.000506	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.13e-06	0.000456	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.04e-06	0.000446	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.97e-06	0.000439	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	3.95e-06	0.000436	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.87e-06	0.000428	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.48e-06	0.000385	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.83e-06	0.000313	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.77e-06	0.000306	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	2.71e-06	0.000299	CbGpPWpGaD
